Cargando…

Incident infection risks depending on oral antidiabetic exposure in insulin-treated type 2 diabetes patients

Dipeptidyl peptidase-4 inhibitors (DPP4is) and sodium glucose cotransporter-2 inhibitors (SGLT2is) have been speculated to have a potential to increase infection risks in type 2 diabetes mellitus (T2DM) patients. We performed a cohort study using the Korean health insurance data to investigate infec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Sanghwa, Jeong, Jiseon, Woo, Yunna, Choi, Yeo Jin, Shin, Sooyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611756/ https://www.ncbi.nlm.nih.gov/pubmed/37891260 http://dx.doi.org/10.1038/s41598-023-45793-x

Ejemplares similares

Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus
por: Choi, Yeo Jin, et al.
Publicado: (2019)

Durability of initial antidiabetic monotherapy and subsequent treatment adjustment patterns among newly treated type 2 diabetes patients
por: Noh, Yoojin, et al.
Publicado: (2018)

Adherence to treatment for diabetes mellitus: validation of instruments for oral antidiabetics and insulin
por: Boas, Lilian Cristiane Gomes-Villas, et al.
Publicado: (2014)

Incident Type 2 Diabetes Risk of Selective Estrogen Receptor Modulators in Female Patients with Breast Cancer
por: Choi, Yeo-Jin, et al.
Publicado: (2021)

Efficacy and Safety of Oral Antidiabetic Drugs in Comparison to Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis
por: Poolsup, Nalinee, et al.
Publicado: (2014)

Insulin versus an oral antidiabetic agent as add-on therapy in type 2 diabetes after failure of an oral antidiabetic regimen: a meta-analysis
por: Gamble, JM, et al.
Publicado: (2008)

How many oral antidiabetic drugs before insulin?
por: Kelwade, Jayant, et al.
Publicado: (2017)

Disparities in Initial Oral Antidiabetic Medication Adherence Among Veterans with Incident Diabetes
por: Gatwood, Justin D., et al.
Publicado: (2018)

Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis
por: Liang, Hui-ling, et al.
Publicado: (2017)

Incidence and predictors of hypoglycemia in Japanese patients with type 2 diabetes treated by insulin glargine and oral antidiabetic drugs in real-life: ALOHA post-marketing surveillance study sub-analysis
por: Odawara, Masato, et al.
Publicado: (2014)

Comparative effectiveness of incident oral antidiabetic drugs on kidney function
por: Hung, Adriana M, et al.
Publicado: (2012)

Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents
por: Philis-Tsimikas, A, et al.
Publicado: (2013)

The Antidiabetic Functions of the Pancreas and Successful Isolation of the Antidiabetic Hormone Insulin
Publicado: (1924)

Insulin Initiation in Insulin-Naïve Korean Type 2 Diabetic Patients Inadequately Controlled on Oral Antidiabetic Drugs in Real-World Practice: The Modality of Insulin Treatment Evaluation Study
por: Kim, Sang Soo, et al.
Publicado: (2015)

Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs
por: Signorovitch, J E, et al.
Publicado: (2013)

Clinical Benefits of Oral Anticoagulant Use in Cancer Patients at Increased Risk for Venous Thromboembolism per Khorana Index
por: Choi, Yeo Jin, et al.
Publicado: (2021)

Glycaemic impact of treatment intensification in patients with type 2 diabetes uncontrolled with oral antidiabetes drugs or basal insulin
por: Buysman, Erin K., et al.
Publicado: (2018)

Safety and efficacy of insulin detemir in type 2 diabetic patients previously treated with oral antidiabetics alone: Results from the Tunisian A(1) chieve cohort
por: Chaib, Larbi
Publicado: (2013)

The association of diabetes mellitus treated with oral antidiabetic drugs and insulin with mortality after transcatheter valve implantation: a 3-year follow-up of the TAVIK registry
por: Tzamalis, Panagiotis, et al.
Publicado: (2019)

Meta-Analysis of Drug Delivery Approaches for Treating Intracellular Infections
por: Shin, Sooyoung, et al.
Publicado: (2022)

Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus
por: Cheng, Chih-Ning, et al.
Publicado: (2020)

Polymorphism of Glucokinase Gene in Non-Insulin Dependent Diabetes Mellitus
por: Kim, Deog-Yoon, et al.
Publicado: (1994)

Comparison of non-insulin antidiabetic agents as an add-on drug to insulin therapy in type 2 diabetes: a network meta-analysis
por: Yoon, Jeong-Hwa, et al.
Publicado: (2018)

Pharmacogenetics of Oral Antidiabetic Drugs
por: Becker, Matthijs L., et al.
Publicado: (2013)

Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development
por: Singh, Desh Deepak, et al.
Publicado: (2022)

Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease
por: Hermansen, Kjeld, et al.
Publicado: (2008)

Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice*
por: Hammer, H, et al.
Publicado: (2007)

Traditional Chinese Medical Care and Incidence of Stroke in Elderly Patients Treated with Antidiabetic Medications
por: Chiao, Yun-Wen, et al.
Publicado: (2018)

Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
por: Choi, Yeo Jin, et al.
Publicado: (2020)

Glycaemic control efficacy of oral antidiabetic drugs in treating type 2 diabetes: a protocol for network meta-analysis
por: Jia, Yongliang, et al.
Publicado: (2015)

Increased osteoprotegerin level is associated with impaired cardiovagal modulation in type-2 diabetic patients treated with oral antidiabetic drugs
por: Jasmine, M. R., et al.
Publicado: (2020)

Rapid Acting Insulin Use and Persistence among Elderly Type 2 Diabetes Patients Adding RAI to Oral Antidiabetes Drug Regimens
por: Sambamoorthi, Usha, et al.
Publicado: (2016)

The Effects of Once-Weekly Dulaglutide and Insulin Glargine on Glucose Fluctuation in Poorly Oral-Antidiabetic Controlled Patients with Type 2 Diabetes Mellitus
por: Wang, Jie, et al.
Publicado: (2019)

Insulin clearance and incretin hormones following oral and “isoglycemic” intravenous glucose in type 2 diabetes patients under different antidiabetic treatments
por: Tura, Andrea, et al.
Publicado: (2022)

Insulin treatment in patients with diabetes mellitus and heart failure in the era of new antidiabetic medications
por: Staszewsky, Lidia, et al.
Publicado: (2022)

Improved glycaemic control and lower hypoglycaemia risk with reduced prior oral antidiabetes drug therapy in patients with type 2 diabetes treated with insulin glargine 300 U/mL
por: Dailey, George, et al.
Publicado: (2018)

Antidiabetic and antihyperlipidemic effects of ethanolic extract of leaves of Punica granatum in alloxan-induced non–insulin-dependent diabetes mellitus albino rats
por: Das, Swarnamoni, et al.
Publicado: (2012)

Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus
por: Jermendy, György, et al.
Publicado: (2012)

Diabetic Euglycemic Ketoacidosis Induced by Oral Antidiabetics Type SGLT2i
por: Velasco de Cos, Guillermo, et al.
Publicado: (2021)

Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs
por: Baser, Onur, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ccm63ld6s3rlr7grr4e2mg9vvm